WHY: The BUTTON post-investment management team initially served our portfolio companies, helping them grow their businesses. We discovered that many entrepreneurs required assistance or advice from experienced experts to reach their next milestones in financing, commercialization, and innovative digitalization.
HOW: By following the methodology of "Executable and Deliverable", we provide systematical solutions to help more entrepreneurs build their companies and accomplish their visions.
Asian Commercialization Strategy
Even if you may be only focused on one major market such as the US, resources from other regions may still be of help as long as the strategy is carefully designed and optimized.
Our tailored “Commercialization Plan” helps you leverage the resources from Asia to improve your profitability, taking into account regulatory pathways, supply chain stability, manufacturing scalability, and manufacturing cost.
Medical device or consumer health companies looking for Asian market penetration or manufacturing
Digital solutions are transforming sectors like Healthcare, Life Sciences, and Pharma. These companies harness scientific breakthroughs and digital innovations for improved treatments and customer-centric products.
Our business service team helps startups and others integrate modern digital trends, from mobile and AI to big-data-driven customer engagement pipelines.
Healthcare, medical device, biotech, or pharma companies that want to leverage innovative digital solutions for production optimization.
Cross-Border Deal Structure Design and Financing Strategy
Cross-border deal structure and financing could be costly if the strategy is not optimized.
Our business service team provides you with customized and strategic assistance during the design and execution of financing, M/A, and company building.
Healthcare, medical device, Biotech, or Pharma companies looking for joint venture, partnership, investment, and M/A with business partners, especially from China
Trusted by Innovative Companies and Partners
Synbio with over 250 scientific staff has developed a full range of DNA reading (sequencing), DNA writing (synthesis), and DNA editing (engineering) capabilities and has delivered satisfactory solutions globally to researchers for various applications, including diagnostic DNA probes, precision medicine, protein production, antibody discovery, vaccine development, novel enzymes, molecular breeding, biofuel implication, etc.